SETD3 and breast carcinoma: Then, we employed SETD3 siRNA knockdown in vitro in a range of well-established human mammary carcinoma cell lines to analyze the role of SETD3 depletion in cytoskeleton-associated functions with relevance to malignant cell behavior.